DIRS.INFO The most relevant business & tech news

☆ Trade Desk shares fall 19% on lower guidance
▼ + stars: | 2023-11-10 | by ( Jake Piazza | In | ) www.cnbc.com time to read: +2 min

Shares of digital ad company The Trade Desk fell 19% Friday morning, a day after the company reported third-quarter results and issued weak revenue guidance. Analysts keyed in on the likelihood of softer ad spending in the December quarter. The Trade Desk is one of many companies that have cited weaker ad spending as a reason to exercise caution or temper expectations for the fourth quarter. Meta , Pinterest and Snap all expressed concern over disrupted ad spending due to the Israel-Hamas war. Wolfe Research analysts are concerned over the sustainability of The Trade Desk's growth in connected TV, which is a significant contributor to the company's revenue.

Persons: Wolfe, Needham, Jonathan Vanian, Michael Bloom Organizations: Trade, Wolfe Research, CTV, Needham Locations: Israel

☆ These luxury stocks won't lose their luster even as sales growth slows to pre-pandemic levels
▼ + stars: | 2023-11-10 | by ( Hakyung Kim | ) www.cnbc.com time to read: +13 min

After three years of record growth, luxury companies are feeling the pain as sales slow to a more normal pace. Nowhere have the struggles of the luxury sector been more prominent than in the French conglomerate LVMH Moet Hennessy Louis Vuitton , the group's bellwether. This dynamic tends to hurt the less-prestigious luxury brands more, according to Rogerio Fujimori, an analyst at Stifel. "Chinese [consumers] are back to Southeast Asia and Japan, but there's still a long way to go in terms of Europe. LVMH and other European luxury brands have been market leaders among European equities since 2021 until the first half of 2023.

Persons: Richemont, Burkhart Grund, LVMH Moet Hennessy Louis Vuitton, Gucci, Ashley Wallace, Bernstein, Luca Sola, Rogerio Fujimori, Fujimori, Wallace, Stifel's Fujimori, there's, Richemont's Grund, —, Fujimori foresees, we've, Hermes, Brunello, Thomas Chauvet, Louis Vuitton, Brunello Cucinelli, LVMH, Dior, Markus Hansen, Hansen, America's Wallace, It's, Vontobel's Hansen, — CNBC's Michael Bloom Organizations: Cartier, Bank of America, U.S, U.S ., EU, Europe, Citi, Bank, Gucci, Bottega Locations: U.S, Europe, Japan, China, Southeast Asia, China's, Thursday's, Kering

☆ Goldman calls this options trading strategy 'systematically profitable'
▼ + stars: | 2023-11-10 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

There are several opportunities over the next month for investors to cash in on a long-standing trend by buying options, according to Goldman Sachs. "We find that call buying around analyst days has been a systematically profitable option buying strategy. The reason the strategy works is that there appears to be an upward bias to share price movement after analyst days that is not priced in to the options market, Goldman said. "Company managements take the opportunity of analyst days to review recent performance, layout strategic priorities, provide/update forward guidance, reveal long-term targets etc. Despite the significance of analyst days, we also observe that the options market tends to underprice volatility around analyst days," the note said.

Persons: Goldman Sachs, Sesha Phani, Goldman, Ingersoll Rand, — CNBC's Michael Bloom Organizations: Defense, L3Harris Technologies Locations: Roblox

☆ These losing stocks could surge as the year winds down, Bank of America says
▼ + stars: | 2023-11-10 | by ( Darla Mercado | Cfp | ) www.cnbc.com time to read: +3 min

One investor's portfolio loser could be another's winning stock as 2023 draws to a close, according to Bank of America. Buy rated and cheap Bank of America screened for buy-rated stocks that fell at least 10% in 2023 through the end of October that were also overweight by long-only funds as of September. However, Bank of America still rates both names as buys – and others on Wall Street spot potential. Retailer Target is another name that made the cut, garnering a buy rating from Bank of America. Other stocks in Bank of America's list include agriculture play Mosaic , life insurer MetLife , defense giant Northrop Grumman , as well as gas and electric utility CenterPoint Energy .

Persons: Savita Subramanian, Dexcom, Insulet, –, Piper Sandler's Matt O'Brien, — CNBC's Michael Bloom Organizations: Bank of America, Internal Revenue, Bank of, Target, MetLife, Northrop, CenterPoint Energy Locations: Bank of America, Bank

☆ Lilly trades at a premium to Ozempic-maker Novo as obesity drugs boom. Here's why, analyst says
▼ + stars: | 2023-11-10 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +6 min

Does Eli Lilly deserve to trade at a premium to Novo Nordisk shares? LLY YTD mountain Eli Lilly shares since the start of the year. According to Shin, Lilly deserves a premium to Novo Nordisk because its portfolio is more diverse and it has less exposure to insulin. NVO YTD mountain Novo Nordisk shares year to date In the coming weeks, Lilly will start rolling out Zepbound to patients. Novo Nordisk is scheduled to release the full results of its Select cardiovascular trial at the American Heart Association conference.

Persons: Eli Lilly, James Shin, Shin, Lilly, We're, Lilly's, Zepbound, Wegovy, Chris Schott, Karsten Munk Knudsen, Novo, Schott, AstraZeneca, Eccogene, David Ricks, — CNBC's Michael Bloom Organizations: Novo Nordisk, Deutsche Bank, Biotech, Pharma, Centers for Disease Control, Novo, CNBC, American Heart Association Locations: U.S, GLP, Novo, Denmarkt

☆ Jefferies upgrades this little-known biotech stock with more than 100% upside
▼ + stars: | 2023-11-10 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +1 min

The firm upgraded shares of the late-stage biotech to buy from hold, lifting its price target to $26 from $18. Shares of Vera Therapeutics have fallen 37.8% this year, but analyst Farzin Haque believes the stock's recent pullback now means an attractive entry point for investors. VERA YTD mountain VERA YTD chart "W/ shares down –30% (vs XBI –13%) since Sept 21 TVTX data release, we have become more optimistic about atacicept (dual BAFF/APRIL) clin profile," Haque wrote. Atacicept, which Vera took over from Merck, is a drug that treats certain autoimmune diseases. "W/ recent increasing focus on eGFR, VERA's OLE data from ph.II for longer-term eGFR data (expected 1Q24) has now become an important catalyst for the stock," Haque said.

Persons: Vera, Jefferies, Vera Therapeutics, Farzin Haque, VERA YTD, VERA, Haque, Lupus nephritis, — CNBC's Michael Bloom Organizations: Vera, Merck Locations: ph.II

☆ Here are Friday's biggest analyst calls: Nvidia, Netflix, Plug Power, Toast BJ's, Arm, Occidental & more
▼ + stars: | 2023-11-10 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Wolfe reiterates Nvidia as outperform Wolfe said it's getting more bullish on the stock over the next several quarters. Wolfe downgrades Occidental Petroleum to peer perform from outperform Wolfe said shares of the oil company will be range bound. Bank of America downgrades FTC Solar to underperform from buy Bank of America said it was wrong about its prior buy rating on the solar stock. Bank of America downgrades CommScope to neutral from buy Bank of America trends are worsening for the tech company. Bank of America initiates Weatherford as buy Bank of America said in its initiation of the global energy company that it's seen a "remarkable turnaround."

Persons: Stephens, Henry Schein, Stifel, it's bullish, Wolfe, it's, Freyr, BTIG, FREY, William Blair, Wells, Baird, Weatherford, Girish Saligram, Gordon Haskett, Haskett, Morgan Stanley, Jefferies, Vera Organizations: Portillo's Inc, JPMorgan, Netflix, Citi, Body Works Citi, Nvidia, Wolfe Alpha, Occidental Petroleum, Bank of America, FTC, sel, RBC, EV Locations: Illumina, Occidental, Wells Fargo, Hawaii, 3Q23, U.S

☆ Goldman is sticking by this beaten-up IPO, sees more than 75% upside
▼ + stars: | 2023-11-09 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

Goldman Sachs thinks Instacart could be poised for a comeback. The firm reiterated a buy rating on the grocery delivery stock alongside a $48 per share price target. The company's initial public offering valued Instacart at roughly $10 billion. CART YTD mountain Instacart stock. Goldman Sachs analyst Eric Sheridan said the long-term view for Instacart remains sound, and the company will benefit from greater adoption of its platform and stronger advertising revenue.

Persons: Goldman Sachs, Instacart, Eric Sheridan, Sheridan, Michael Bloom Organizations: CART

☆ 'Golden opportunity': Morgan Stanley says it's a good time to buy gold stocks — and names its top global picks
▼ + stars: | 2023-11-09 | by ( Amala Balakrishner | ) www.cnbc.com time to read: +2 min

Now is a good time to buy gold stocks, according to Morgan Stanley. Notably, gold stocks underperformed gold prices by about 20% in the last three months, the investment bank's analysts, led by Sandeep Peety, wrote in a Nov. 2 note. Morgan Stanley named several stocks to play the "golden opportunity." 'Preferred play' Morgan Stanley named Endeavour Mining , a London-headquartered multinational mining company, as its "preferred play." Other overweight-rated stocks Other gold mining companies that the investment bank gave an overweight rating include Australia's Evolution Mining and Regis Resources and China's Zijin Mining Group .

Persons: Morgan Stanley, Sandeep Peety, — CNBC's Michael Bloom Organizations: Endeavour Mining, Regis Resources, Zijin Mining, Mining, Compania De Locations: Israel, London, EDV, Ivory, Massawa, Senegal, Compania De Minas Buenaventura

☆ There's a new entry into the weight loss drug boom. Here's the outlook for the stock
▼ + stars: | 2023-11-09 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

AstraZeneca is the latest player to enter the weight loss drug arena, a market which some analysts have forecasted could reach $100 billion by 2030 . The GLP-1 drug market is currently dominated by two players: Novo Nordisk , which sells Type 2 diabetes treatment Ozempic and weight loss medication Wegovy, and Eli Lilly , which sells Mounjaro as a treatment for Type 2 diabetes. Lilly just had the weight loss version of its drug, Zepbound , approved by the Food and Drug Administration. It's still early days for AstraZeneca's ECC5004 drug, which is being assessed in a U.S.-based phase 1 trial involving patients with Type 2 diabetes. He currently rates AstraZeneca stock as overweight.

Persons: Eccogene, Wegovy, Eli Lilly, Lilly, It's, Colin White, James Gordon, Morgan Stanley, Mark Purcell, AstraZeneca's Farxiga, Purcell, Michael Bloom, Christina Cheddar, Berk Organizations: AstraZeneca, Novo Nordisk, Food and Drug Administration, Centers for Disease Control, UBS, Wall Street, JPMorgan Locations: U.S

☆ Beware these companies due to report earnings that have negative profit momentum
▼ + stars: | 2023-11-09 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +4 min

CNBC Pro screened for the S & P 500 companies still reporting next week that analysts have expressed the most caution on — by cutting their earnings estimates ahead of the reports. Analyst consensus earnings estimates are down at least 5% over the past three months. Analyst consensus earnings estimates are down at least 5% over the past six months. CTLT YTD mountain Catalent YTD chart "Catalent (CTLT) became a very noticeable laggard in the life science space about fifteen months ago. Meat producer Tyson Foods , which is due to report earnings premarket on November 13, was also among the stocks with negative earnings momentum.

Persons: Gordon Haskett, Don Bilson, Bilson, Catalent, Michael Lasser, Lasser, Morgan Stanley, BBWI, Alex Straton, Tyson Foods, — CNBC's Michael Bloom Organizations: CNBC Pro, Biotechnology, Sarepta Therapeutics, Dystrophy, UBS, 3Q, Body Locations: Columbus , Ohio, Bath

☆ Patient Disney shareholders get some good news: The dividend is coming back
▼ + stars: | 2023-11-09 | by ( Yun Li | ) www.cnbc.com time to read: +2 min

For the first time since 2020, Disney is planning to resume paying a dividend to shareholders as the media giant continues its turnaround amid historic industry shifts . "To that end, we will be recommending to the board that they declare a dividend by the end of this calendar year." Activist investor Nelson Peltz's Trian Fund Management, with $2.5 billion of Disney shares , has voiced his concerns about the elimination of dividends. Trian hasn't made a public statement since it ended its last activist campaign against Disney in January. Morgan Stanley said it looks forward to such a move, noting that Disney also suggested a return to share repurchases.

Persons: Kevin Lansberry, Nelson Peltz's, Trian hasn't, Lansberry, Bernstein, Morgan Stanley, Disney, Philip Cusick, — CNBC's Michael Bloom Organizations: Disney, Fund Management, Wall Street, ESPN

☆ Here are Thursday's biggest analyst calls: Nvidia, Disney, Tesla, Instacart, Arm, Rivian, Target & more
▼ + stars: | 2023-11-09 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Here are Thursday's biggest calls on Wall Street: Goldman Sachs initiates Apellis Pharmaceuticals as buy Goldman initiated the biotech company with a buy and says it sees "continued execution." Bank of America reiterates Disney as buy Bank of America said it's standing by its buy rating after Wednesday's earnings report. Goldman Sachs reiterates Arm as overweight Goldman said it's sticking with its buy rating after the stock's earnings report on Wednesday. Goldman Sachs reiterates Instacart as buy Goldman said it's sticking with its buy rating on the grocery delivery company after Instacart's earnings report on Wednesday. Morgan Stanley reiterates Rivian as overweight Morgan Stanley said it's sticking with its overweight rating on the electric vehicle company. "

Persons: Goldman Sachs, Goldman, Tesla, WK Kellogg, Kellogg, Wolfe, Instacart, Morgan Stanley, Rivian, Eli Lilly, MRK's Keytruda, Evercore, it's bullish, Parker, Wells, it's, Hein Schumacher Organizations: Apellis Pharmaceuticals, HSBC, Tesla, Barclays, JPMorgan, Bank of America, Disney, ARM, Deutsche Bank, Deutsche, Merck, pharma, TAP, Industrial, Nvidia, Anheuser, Busch InBev, Bud, Offshore, Unilever, OW, Citi Locations: North America, Montrose

☆ These are the stocks that will benefit — and lose out — from the wellness trend, Morgan Stanley says
▼ + stars: | 2023-11-08 | by ( Weizhen Tan | ) www.cnbc.com time to read: +5 min

The Covid-19 pandemic was a big factor behind the rising focus on weight and its implications for health, Morgan Stanley noted. CNBC Pro takes a look at the stocks Morgan Stanley says will be affected by those trends — both positively and negatively. Beneficiaries Morgan Stanley said "functional" foods, waters, skincare and cosmetics, and consumer health should be well positioned. Morgan Stanley upgraded its rating for Danone to "overweight." At risk Alcoholic beverages and soft drinks appear to be among categories most affected by the GLP-1 trend and the focus on wellness, Morgan Stanley said.

Persons: they're, Morgan Stanley, Mounjaro, Nestle, Remy Cointreau, Beers, Brewer, there's, Britvic, CNBC's Michael Bloom Organizations: Wellness, McKinsey, GLP, Walmart, CNBC Pro, Danone, United States —, Nestle, L'Oreal, Beiersdorf, Diageo, Brewer Anheuser, Busch Inbev Locations: Europe, United States, British

☆ Here’s what's worrying analysts going into Disney’s earnings report
▼ + stars: | 2023-11-08 | by ( Brian Evans | ) www.cnbc.com time to read: +4 min

Analysts are eyeing updates on Disney's direct-to-consumer business and ESPN ahead of fiscal fourth-quarter results Wednesday, as the company pivots further into streaming. The analyst has a buy rating on Disney stock with a $125 per share price target, down from $128. Here's what other analysts on Wall Street are saying ahead of Disney's results. MoffettNathanson - buy rating MoffettNathanson has a buy rating on Disney stock and a $115 per share price target. Wells Fargo - overweight rating Wells Fargo analyst Steven Cahall rates the stock overweight with a $110 per share price target.

Persons: Disney, Goldman Sachs, Brett Feldman, Jason Bazinet, Morgan Stanley, Ben Swinburne, Michael Nathanson, Nathanson, Wells, Steven Cahall, Cahall, Michael Bloom Organizations: ESPN, Disney, DIS, Hulu, Comcast, Citi, Press, Sports, CNBC

☆ Bank of America says there are two things that will drive the next bull run in stocks
▼ + stars: | 2023-11-08 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Artificial intelligence's influence on increased productivity and a strong consumer could underpin the next bull run on Wall Street, according to Bank of America. "I think this is actually a very underappreciated bull case," she added. The "Magnificent Seven" stocks in the S & P 500 have been large growth drivers for Wall Street for most of 2023. As long as those factors don't change, we think that the consumer can hang in there," she said. "We've had a big move in rates, but companies have so far been able to withstand it.

Persons: Savita Subramanian, Subramanian, it's, We've, Michael Bloom Organizations: Bank of America, Wall, Nvidia, Apple, Federal Reserve, Survey

☆ ‘The gift that keeps on giving’: Morgan Stanley likes the memory sector and picks its top stocks
▼ + stars: | 2023-11-08 | by ( Amala Balakrishner | ) www.cnbc.com time to read: +3 min

The tech theme has been reigning supreme this year and one segment in particular stands out to Morgan Stanley: the memory sector. The Morgan Stanley analysts have penciled in a 14% price hike for NAND and 10% increase for DRAM this quarter. Even so, Morgan Stanley says that the recovery in the memory sector is just starting and is still "front-running a lot of good things that are supposed to happen much later." Top pick and buy-rated stocks The optimistic outlook for the memory sector spells good news for a raft of stocks in Asia. Morgan Stanley is overweight on the stock and gives it a price target of 500 New Taiwanese dollars ($15.52), or around 1% upside.

Persons: Morgan Stanley, Morgan, Shawn Kim, Nvidia, — CNBC's Michael Bloom Organizations: Korean chipmaker SK Hynix, Samsung Electronics, —, SK Hynix, Korean, SK Hynix —, Samsung, Phison Electronics Locations: HBM, Asia

☆ Here are Wednesday's biggest analyst calls: Apple, Rivian, Datadog, DraftKings, Lucid, Target, Adobe & more
▼ + stars: | 2023-11-08 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Wednesday's biggest calls on Wall Street: UBS reiterates Apple as neutral UBS said its checks show wait times for Apple's iPhone Pro and Pro Max have fallen. UBS reiterates Target as buy UBS lowered its price target on the stock to $174 per share from $184 but said it's standing by Target shares. Bank of America upgrades Fluence Energy to buy from neutral Bank of America said the energy storage is the next big thing in renewables. Bank of America reiterates Rivian as buy Bank of America said Rivian is "still in [the] right place/time with right product/strategy." Bank of America reiterates DraftKings as buy Bank of America said it's bullish heading in to DraftKing's investor day next week.

Persons: Pro Max, Wells, Isaac, it's, Cantor Fitzgerald, Cantor, TD Cowen downgrades Estee Lauder, Estee Lauder, Rivian, it's bullish, Goldman Sachs, Goldman, Raymond James downgrades Masimo, Raymond James, DraftKings, Bernstein, Mizuho downgrades Datadog, DDOG, MCHP Organizations: UBS, Apple, Pro, Target, 3Q, Citi, Bank of America, Energy, of America, South Korea Travel, EV, Susquehanna, TAM, Adobe, Mizuho, JPMorgan Locations: China, Europe, Japan, Mainland China, Hainan, MASI, bottoming

☆ UBS says these software stocks can maximize AI, have 30% upside
▼ + stars: | 2023-11-07 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

The price target on three of those names implies upside of 30% or more. "Rate-fueled multiple compression offers investors opportunistic entry into high-quality, mission critical software businesses with TAMs [total addressable markets] growing low double-digits," analyst Kevin McVeigh wrote. Cloud-based software provider Intapp could also have more than 30% upside despite rallying 43% year to date, according to McVeigh. "We see a well-positioned, predictable model, coupled with constructive fundamentals positioned for core consistent 4-7% organic revenue growth," the analyst wrote. McVeigh also included Thomson Reuters on his list of buy-rated names, although he only sees 18% upside for the stock.

Persons: Kevin McVeigh, McVeigh, — CNBC's Michael Bloom Organizations: UBS, Clearwater Analytics, C Technologies, Thomson Reuters, Nvidia

☆ Re/Max shares tumble as Morgan Stanley warns of litigation risks in wake of landmark realtor conspiracy ruling
▼ + stars: | 2023-11-07 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Shares of Re/Max sank Tuesday after Morgan Stanley warned the brokerage firm could be in for some rocky times ahead in the wake of a landmark ruling against realtors and brokerages. Morgan Stanley thinks the ruling could increase the risk of further litigation and expensive settlements. The bank downgraded Re/Max to underweight from equal weight and slashed its price target to $9 per share from $19.50. The brokerages typically take a slice of its agent's earnings. Shares of Re/Max have already lost more than 40% year to date.

Persons: Max, Morgan Stanley, Ronald Kamdem, Kamdem, Sellers, — CNBC's Michael Bloom Organizations: realtors, brokerages, National Association of Realtors

☆ Top auto analyst Jonas lists 4 things Tesla could do to stop its slide
▼ + stars: | 2023-11-07 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Tesla shares won't stop falling unless the electric vehicle maker enacts some serious changes, according to Morgan Stanley. Tesla stock closed Tuesday below the $220 level, meaning it has lost about a quarter of its value since notching July intraday highs above $295. "Tesla investor sentiment is low, but that's not enough by itself to halt the negative momentum." TSLA YTD mountain Tesla stock this year But there are a few things Tesla can do to halt its tumble and reestablish itself as a leader, Jonas said. Executing model expansion on the Cybertruck and other models outside of the S, X, 3 and Y families could help investors' sentiment, he said.

Persons: Tesla, Morgan Stanley, Adam Jonas, Jonas, he's, — CNBC's Michael Bloom

☆ Bernstein says to buy these crypto stocks to play the expected bitcoin ETF and halving
▼ + stars: | 2023-11-07 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Crypto investors are returning attention to two big catalysts – a bitcoin ETF and the Bitcoin halving – and Bernstein has ways to play each. With that backdrop, Bernstein recently initiated coverage on bitcoin mining stocks, with an outperform rating on both Riot Platforms and CleanSpark and a market perform rating on Marathon Digital . "Right now, you should buy RIOT and CLSK, with clear market catalysts around bitcoin ETF approval in early 2024," Bernstein analyst Gautam Chhugani said in a note Monday. Further down the road, there's the next bitcoin halving, which is expected in the spring of 2024. It happens approximately every four years, when the reward for mining bitcoin is cut in half as mandated in the Bitcoin code to reduce the supply of the cryptocurrency over time.

Persons: Bernstein, Crypto, Gautam Chhugani, It's, Chhugani, it's, CNBC's Michael Bloom Organizations: Marathon

☆ S&P 500 returns tend to be measly in the 12 months leading up to a presidential election
▼ + stars: | 2023-11-07 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

The 2024 U.S. presidential election is now only 12 months away, with the primary season set to begin Jan. 15. While every election year brings with it a unique mix of political and macroeconomic conditions, Goldman Sachs' portfolio strategy research team says equity returns tend to be weaker than average in the 12 months leading up to a presidential election. Since 1984, the average S & P 500 return on election years is only 4%, according to Goldman. When looking more broadly from 1932, the S & P 500 has averaged returns of 7% during an election year and 9% outside of election years. "Post-election returns have typically been stronger when the election resulted in a divided government than a unified government, especially in the case of a wave election," Kostin said.

Persons: Goldman Sachs, Goldman, Louis, David Kostin, Kostin, — CNBC's Michael Bloom Organizations: Louis Federal, Tech

☆ Analysts say these growth stocks are set to jump even further — giving them over 30% upside
▼ + stars: | 2023-11-07 | by ( Weizhen Tan | ) www.cnbc.com time to read: +2 min

Higher-for-longer interest rates are especially bad for growth stocks. For those keen on getting back into the growth corner of the market, CNBC Pro screened for stocks in the iShares Russell 1000 Growth ETF that have further upside. Despite its huge gains this year, it was given more upside by analysts — potentially 45.5% based on the average price target, according to FactSet. Other stocks that made the list include cloud companies Okta and Snowflake , with over 30% potential upside each. Fintech-related stocks such as PayPal and Block also showed up, as did many health-care and pharmaceutical stocks.

Persons: Stocks, Russell, It's, — CNBC's Michael Bloom Organizations: Nasdaq, U.S . Federal Reserve, Citi, CNBC Pro, Nvidia, PayPal Locations: Snowflake

☆ Goldman double upgrades this under-the-radar cloud stock with nearly 40% upside
▼ + stars: | 2023-11-07 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Cloud computing platform DigitalOcean is at an attractive entry point, according to Goldman Sachs. Analyst Gabriela Borges upgraded DigitalOcean to buy from sell and maintained her price target of $33, which implies the stock could jump 38.4% over the next 12 months. Borges cited the stock's significant underperformance — DigitalOcean is up nearly 6% this year, while the Nasdaq Composite has gained 30% — as an opportunity for investors. The underperformance has likely been driven by a cyclical normalization in cloud optimization spending, according to Borges. Borges noted overhang from DigitalOcean's ongoing search for a new CEO since late August.

Persons: Goldman Sachs, Gabriela Borges, DigitalOcean, Borges, DigitalOcean's, — CNBC's Michael Bloom Organizations: Nasdaq

Search resuls for: "Michael Bloom"

25 mentions found